A 33-year-old man with a history of intermittent asthma presented with 3 months of dyspnea on exertion, which developed approximately 2 weeks after infection with SARS-CoV-2. His acute COVID-19 symptoms resolved after 5 days and did not require hospitalization. At presentation, his physical examination findings were normal and peripheral oxygen saturation was 97% at rest. Laboratory testing, chest radiographic imaging, chest computed tomographic scan, echocardiography, and pulmonary function testing results were normal. To further evaluate his dyspnea on exertion, the patient underwent cardiopulmonary exercise testing (CPET) on a cycle ergometer with arterial blood gas samples obtained from an indwelling radial artery catheter. Continuous 12-lead electrocardiogram (ECG) findings showed no evidence of arrythmia or ischemia, and the patient stopped exercise due to leg fatigue after 15 minutes. Select exercise data are presented in the Table and Figure.
Table.
Patient’s Select Cardiopulmonary Exercise Testing (CPET) Results
| Measurement | Predicteda | Measured | Percent predicted, % |
|---|---|---|---|
| VO2max, L/min | 3.31 | 2.1 | 64 |
| Maximum heart rate/min | 187 | 164 | 88 |
| Maximum oxygen pulseb | 18 | 13 | 72 |
| Anaerobic threshold, L/min | 1.32 | 0.85 | 25 |
| Maximum blood pressure, mm Hg | 170/86 | ||
| Maximum minute ventilation, L/minc | 89 | ||
| Exercise breathing reserve, L/mind | >15 | 45 | |
| VE/VCO2 at anaerobic threshold | <34 | 31 | |
| Pao2 at maximum exercise, mm Hg | 83.6 | ||
| PaCO2 at maximum exercise, mm Hg | 29.6 | ||
| Arterial pH at maximum exercise | 7.37 |
Abbreviations: Pao2, arterial oxygen content; VE/VCO2, minute ventilation/carbon dioxide production; V˙ O2max, maximum rate of oxygen consumption.
Predicted values were derived from Clinical Exercise Testing, 4th Edition.1
V˙ O2 divided by heart rate at maximum exercise.
Respiratory rate multiplied by tidal volume at maximum exercise.
Maximal voluntary ventilation minus maximal ventilation at maximum exercise.
Figure.
Vertical dashed lines indicate the beginning of the unloaded cycling, the start of increasing work at 25 W/min, and the start of recovery. A, The horizontal line indicates the patient’s predicted . B, The horizontal line indicates the patient’s predicted maximum heart rate. The patient’s oxygen pulse (a surrogate for stroke volume) did not meet the predicted maximum oxygen pulse, indicated with a blue arrowhead.
Answer
B. Cardiovascular limitation to exercise
Test Characteristics
CPET is a specialized type of exercise stress test performed on a stationary bicycle or treadmill during which progressively increasing resistance is applied until an individual is unable to continue exercising. During CPET, continuous ECG, continuous pulse oximetry, blood pressure monitoring, breath-by-breath measurement of oxygen and carbon dioxide, and arterial blood gas measurements are used to evaluate an individual’s cardiovascular, respiratory, and skeletal muscle responses to exercise.1 CPET demonstrates whether an individual has decreased exercise capacity and can provide information about the cause(s) of exercise intolerance that are not identified by previous testing performed at rest.2,3 The maximum rate of oxygen consumption () is determined by the efficiency of skeletal muscle, cardiovascular, and respiratory systems. A that is lower than predicted for an individual’s age and sex indicates reduced exercise capacity.
During CPET, the respiratory response to maximal exercise can be determined by an individual’s minute ventilation (respiratory rate times tidal volume), ventilatory efficiency (minute ventilation/carbon dioxide production), exercise breathing reserve, continuous pulse oximetry, and arterial blood gas analysis. The cardiovascular response to maximum exercise is assessed by ECG, heart rate, systolic and diastolic blood pressure, and oxygen pulse. The oxygen pulse, defined as the ratio of V˙o2 to heart rate, provides an indirect estimate of stroke volume and typically increases with increasing workload.1–3 Typical Medicare reimbursement for CPET in the US in 2021 was approximately $260.
Application of Test Result to This Patient
During CPET, this patient demonstrated reduced exercise tolerance, achieving only 64% of predicted (Table and Figure, A). He had no evidence of a ventilatory limitation to exercise, based on his normal ventilatory efficiency, normal exercise breathing reserve, no desaturation on continuous pulse oximetry, and no hypoxemia on arterial blood gas at maximum exercise.2,3 However, his CPET results demonstrated a cardiovascular limitation to exercise, shown by his low anaerobic threshold, the point at which lactic acid starts to accumulate in muscles due to anaerobic metabolism, along with a reduced maximum oxygen pulse and flattened oxygen pulse curve (Table and Figure, B). Although a low oxygen pulse and flattened oxygen pulse curve are typically caused by heart failure or myocardial ischemia, continuous ECG monitoring during CPET did not reveal evidence of myocardial ischemia and the patient’s recent echocardiogram showed normal biventricular function. Therefore, his cardiovascular limitation to exercise may have resulted from preload insufficiency due to low venous pressure associated with dysautonomia4or from decreased peripheral muscle oxygen extraction due to mitochondrial or microvascular abnormalities.5
A study of 10 patients with recent COVID-19 infection and no history of cardiopulmonary disease identified a marked reduction in during CPET primarily due to a reduced systemic oxygen extraction.6Treatment of patients with dyspnea after COVID-19 due to impaired extraction of oxygen involves implementation of a gradual, paced exercise regimen.7
What Are Alternative Diagnostic Testing Approaches?
Invasive CPET involves insertion of a catheter in the pulmonary artery and radial artery to provide direct hemodynamic and blood gas analysis during CPET, which can help differentiate decreased peripheral extraction of oxygen from impaired oxygen delivery.6,8
Patient Outcome
Based on CPET findings, the patient demonstrated a cardiovascular limitation to exercise, either due to preload insufficiency or decreased peripheral muscle oxygen extraction. A gradual reintroduction of exercise with a heart rate target of 125 beats/min to 130 beats/min was recommended. The patient adhered to this exercise plan and, 4 months after CPET, reported only mild residual intermittent dyspnea on exertion.
HOW DO YOU INTERPRET THESE TEST RESULTS?
Cardiovascular and ventilatory limitation to exercise
Cardiovascular limitation to exercise
No limitation to exercise (normal cardiopulmonary exercise testing results)
Ventilatory limitation to exercise
Clinical Bottom Line.
Cardiopulmonary exercise testing (CPET) determines whether an individual has a limitation to exercise based on achieved maximum rate of oxygen consumption, .
CPET can identify the cause(s) of dyspnea on exertion that remain unexplained by testing performed at rest.
Reduced exercise tolerance after COVID-19 infection has been reported, with individuals demonstrating a cardiovascular limitation on CPET despite normal echocardiography and electrocardiogram findings.
Funding/Support:
Dr Petrache reported receipt of financial support from the Wollowick Chair in COPD Research.
Role of the Funder/Sponsor:
The funder had no role in the preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.
Footnotes
Conflict of Interest Disclosures: Dr Petrache reported receiving personal fees from Allinaire and Ceramedix outside the submitted work. Dr Mohning reported receiving consulting fees from Diffusion Pharmaceuticals outside the submitted work. No other disclosures were reported.
Additional Contribution: We thank Iñigo San-Millán, PhD (University of Colorado School of Medicine), for his contributions, including discussion and review of the manuscript. He did not receive compensation for his contributions. We also thank the patient for granting permission to publish this information.
REFERENCES
- 1.Jones NL. Clinical Exercise Testing. 4th ed. WB Saunders; 1997. [Google Scholar]
- 2.Wasserman K, Whipp B, Sietsema KE, Sue DY, Stringer WW, Ward SA. Principles of Exercise Testing and Interpretation. Wolters Kluwer; 2021. [Google Scholar]
- 3.American Thoracic Society; American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277. [DOI] [PubMed] [Google Scholar]
- 4.Oldham WM, Lewis GD, Opotowsky AR, et al. Unexplained exertional dyspnea caused by low ventricular filling pressures. Pulm Circ. 2016;6(1):55–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.de Boer E, Petrache I, Goldstein NM, et al. Decreased fatty oxidation and altered lactate production during exercise in post-acute COVID-19 patients. Am J Respir Crit Care Med. 2022;205(1):126–129. doi: 10.1164/rccm.202108-1903LE [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Singh I, Joseph P, Heerdt PM, et al. Persistent exertional intolerance after COVID-19. Chest. 2021; 161(1):54–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Salman D, Vishnubala D, Le Feuvre P, et al. Returning to physical activity after COVID-19. BMJ. 2021;372:m4721. doi: 10.1136/bmj.m4721 [DOI] [PubMed] [Google Scholar]
- 8.Maron BA, Cockrill BA, Waxman AB, Systrom DM. The invasive cardiopulmonary exercise test. Circulation. 2013;127(10):1157–1164. [DOI] [PubMed] [Google Scholar]

